Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valacyclovir Augmentation in Schizophrenia
NCT01794897Phase 4Completed
- Sponsor
- University of Pittsburgh
- Start
- Feb 2013
- Primary completion
- Sep 2016
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of valaciclovir in schizophrenia, schizoaffective disorder, sponsored by University of Pittsburgh. Started Feb 2013; status: completed.
02
Drugs
valaciclovir
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT01794897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01794897.